258 related articles for article (PubMed ID: 38141933)
1. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.
Wang X; Zhang W; Zeng S; Wang L; Wang B
Acta Biomater; 2024 Feb; 175():262-278. PubMed ID: 38141933
[TBL] [Abstract][Full Text] [Related]
2. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y
Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869
[TBL] [Abstract][Full Text] [Related]
3. Sequential Nano-Penetrators of Capillarized Liver Sinusoids and Extracellular Matrix Barriers for Liver Fibrosis Therapy.
Zhang LF; Wang XH; Zhang CL; Lee J; Duan BW; Xing L; Li L; Oh YK; Jiang HL
ACS Nano; 2022 Sep; 16(9):14029-14042. PubMed ID: 36036898
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy.
Fan QQ; Zhang CL; Qiao JB; Cui PF; Xing L; Oh YK; Jiang HL
Biomaterials; 2020 Feb; 230():119616. PubMed ID: 31837823
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid inhibits adhesion of hepatic stellate cells in spite of its stimulation of DNA synthesis.
Cho MK; Lee GH; Park EY; Kim SG
Tissue Cell; 2004 Oct; 36(5):293-305. PubMed ID: 15385147
[TBL] [Abstract][Full Text] [Related]
6. Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis.
Wang K; Chen H; Zheng J; Chen J; Chen Y; Yuan Y
J Control Release; 2024 Apr; 368():219-232. PubMed ID: 38367862
[TBL] [Abstract][Full Text] [Related]
7. Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis.
Li Y; Zhang T; Zhang J; Liu Q; Jia Q; Chen W; Tang Q; Xiong Y; Xia Y; Xu Y; Mo L; Huang Y; He J
Biomaterials; 2023 Oct; 301():122232. PubMed ID: 37418856
[TBL] [Abstract][Full Text] [Related]
8. Sequential delivery for hepatic fibrosis treatment based on carvedilol loaded star-like nanozyme.
Lu Q; Zhou Y; Xu M; Liang X; Jing H; Wang X; Li N
J Control Release; 2022 Jan; 341():247-260. PubMed ID: 34826531
[TBL] [Abstract][Full Text] [Related]
9. Co-encapsulation of collagenase type I and silibinin in chondroitin sulfate coated multilayered nanoparticles for targeted treatment of liver fibrosis.
Luo J; Zhang Z; Zeng Y; Dong Y; Ma L
Carbohydr Polym; 2021 Jul; 263():117964. PubMed ID: 33858569
[TBL] [Abstract][Full Text] [Related]
10. Antioxidative Hyaluronic Acid-Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy.
Shinn J; Park S; Lee S; Park N; Kim S; Hwang S; Moon JJ; Kwon Y; Lee Y
ACS Nano; 2024 Feb; 18(6):4704-4716. PubMed ID: 38288705
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
[TBL] [Abstract][Full Text] [Related]
12. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
Shi Z; Ren M; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
[TBL] [Abstract][Full Text] [Related]
13. CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis.
Li R; Zhang J; Liu Q; Tang Q; Jia Q; Xiong Y; He J; Li Y
Acta Biomater; 2023 Sep; 168():484-496. PubMed ID: 37392933
[TBL] [Abstract][Full Text] [Related]
14. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of pirfenidone and siRNA in ZIF-based nanoparticles for dual inhibition of hepatic stellate cell activation in liver fibrotic therapy.
Wang K; Chen H; Qin S; Chen S; Zhang Q; Chen J; Di D; Su G; Yuan Y
Colloids Surf B Biointerfaces; 2023 Nov; 231():113567. PubMed ID: 37797465
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy.
Ji D; Wang Q; Zhao Q; Tong H; Yu M; Wang M; Lu T; Jiang C
J Nanobiotechnology; 2020 Jun; 18(1):86. PubMed ID: 32513194
[TBL] [Abstract][Full Text] [Related]
17. Igf2bp2 knockdown improves CCl
Xu Z; He B; Jiang Y; Zhang M; Tian Y; Zhou N; Zhou Y; Chen M; Tang M; Gao J; Peng F
Int Immunopharmacol; 2022 Sep; 110():108987. PubMed ID: 35820364
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis.
Son G; Hines IN; Lindquist J; Schrum LW; Rippe RA
Hepatology; 2009 Nov; 50(5):1512-23. PubMed ID: 19790269
[TBL] [Abstract][Full Text] [Related]
19. Targeting Activated Hepatic Stellate Cells Using Collagen-Binding Chitosan Nanoparticles for siRNA Delivery to Fibrotic Livers.
Azzam M; El Safy S; Abdelgelil SA; Weiskirchen R; Asimakopoulou A; de Lorenzi F; Lammers T; Mansour S; Tammam S
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32630415
[TBL] [Abstract][Full Text] [Related]
20. Collagenase loaded chitosan nanoparticles for digestion of the collagenous scar in liver fibrosis: The effect of chitosan intrinsic collagen binding on the success of targeting.
El-Safy S; Tammam SN; Abdel-Halim M; Ali ME; Youshia J; Shetab Boushehri MA; Lamprecht A; Mansour S
Eur J Pharm Biopharm; 2020 Mar; 148():54-66. PubMed ID: 31945489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
